IBDEI0ES ; ; 03-MAY-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,36997,1,4,0)
;;=4^N50.812
;;^UTILITY(U,$J,358.3,36997,2)
;;=^5138928
;;^UTILITY(U,$J,358.3,36998,0)
;;=N50.811^^107^1484^109
;;^UTILITY(U,$J,358.3,36998,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,36998,1,3,0)
;;=3^Testicular Pain,Right Side
;;^UTILITY(U,$J,358.3,36998,1,4,0)
;;=4^N50.811
;;^UTILITY(U,$J,358.3,36998,2)
;;=^5138927
;;^UTILITY(U,$J,358.3,36999,0)
;;=N35.919^^107^1484^114
;;^UTILITY(U,$J,358.3,36999,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,36999,1,3,0)
;;=3^Urethral Stricture,NOS,Male
;;^UTILITY(U,$J,358.3,36999,1,4,0)
;;=4^N35.919
;;^UTILITY(U,$J,358.3,36999,2)
;;=^5157412
;;^UTILITY(U,$J,358.3,37000,0)
;;=N35.92^^107^1484^113
;;^UTILITY(U,$J,358.3,37000,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37000,1,3,0)
;;=3^Urethral Stricture,NOS,Female
;;^UTILITY(U,$J,358.3,37000,1,4,0)
;;=4^N35.92
;;^UTILITY(U,$J,358.3,37000,2)
;;=^5157413
;;^UTILITY(U,$J,358.3,37001,0)
;;=R82.81^^107^1484^101
;;^UTILITY(U,$J,358.3,37001,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37001,1,3,0)
;;=3^Pyuria
;;^UTILITY(U,$J,358.3,37001,1,4,0)
;;=4^R82.81
;;^UTILITY(U,$J,358.3,37001,2)
;;=^101879
;;^UTILITY(U,$J,358.3,37002,0)
;;=N18.30^^107^1484^17
;;^UTILITY(U,$J,358.3,37002,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37002,1,3,0)
;;=3^Chronic Kidney Disease,Stage 3 Unspec
;;^UTILITY(U,$J,358.3,37002,1,4,0)
;;=4^N18.30
;;^UTILITY(U,$J,358.3,37002,2)
;;=^5159286
;;^UTILITY(U,$J,358.3,37003,0)
;;=N18.31^^107^1484^18
;;^UTILITY(U,$J,358.3,37003,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37003,1,3,0)
;;=3^Chronic Kidney Disease,Stage 3a
;;^UTILITY(U,$J,358.3,37003,1,4,0)
;;=4^N18.31
;;^UTILITY(U,$J,358.3,37003,2)
;;=^5159287
;;^UTILITY(U,$J,358.3,37004,0)
;;=N18.32^^107^1484^19
;;^UTILITY(U,$J,358.3,37004,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37004,1,3,0)
;;=3^Chronic Kidney Disease,Stage 3b
;;^UTILITY(U,$J,358.3,37004,1,4,0)
;;=4^N18.32
;;^UTILITY(U,$J,358.3,37004,2)
;;=^5159288
;;^UTILITY(U,$J,358.3,37005,0)
;;=G44.1^^107^1485^10
;;^UTILITY(U,$J,358.3,37005,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37005,1,3,0)
;;=3^Vascular Headache NEC
;;^UTILITY(U,$J,358.3,37005,1,4,0)
;;=4^G44.1
;;^UTILITY(U,$J,358.3,37005,2)
;;=^5003934
;;^UTILITY(U,$J,358.3,37006,0)
;;=G43.909^^107^1485^6
;;^UTILITY(U,$J,358.3,37006,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37006,1,3,0)
;;=3^Migraine,Unspec,Not Intractable
;;^UTILITY(U,$J,358.3,37006,1,4,0)
;;=4^G43.909
;;^UTILITY(U,$J,358.3,37006,2)
;;=^5003909
;;^UTILITY(U,$J,358.3,37007,0)
;;=G44.009^^107^1485^1
;;^UTILITY(U,$J,358.3,37007,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37007,1,3,0)
;;=3^Cluster Headache,Unspec,Not Intractable
;;^UTILITY(U,$J,358.3,37007,1,4,0)
;;=4^G44.009
;;^UTILITY(U,$J,358.3,37007,2)
;;=^5003921
;;^UTILITY(U,$J,358.3,37008,0)
;;=G44.40^^107^1485^5
;;^UTILITY(U,$J,358.3,37008,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37008,1,3,0)
;;=3^Medication Overuse Headache,Not Intractable
;;^UTILITY(U,$J,358.3,37008,1,4,0)
;;=4^G44.40
;;^UTILITY(U,$J,358.3,37008,2)
;;=^5003947
;;^UTILITY(U,$J,358.3,37009,0)
;;=G44.89^^107^1485^2
;;^UTILITY(U,$J,358.3,37009,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37009,1,3,0)
;;=3^Headache Syndrome NEC
;;^UTILITY(U,$J,358.3,37009,1,4,0)
;;=4^G44.89
;;^UTILITY(U,$J,358.3,37009,2)
;;=^5003954
;;^UTILITY(U,$J,358.3,37010,0)
;;=G44.84^^107^1485^8
;;^UTILITY(U,$J,358.3,37010,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37010,1,3,0)
;;=3^Primary Exertional Headache
;;^UTILITY(U,$J,358.3,37010,1,4,0)
;;=4^G44.84
;;^UTILITY(U,$J,358.3,37010,2)
;;=^336563
;;^UTILITY(U,$J,358.3,37011,0)
;;=G44.301^^107^1485^7
;;^UTILITY(U,$J,358.3,37011,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37011,1,3,0)
;;=3^Post-Traumatic Headache,Unspec,Intractable
;;^UTILITY(U,$J,358.3,37011,1,4,0)
;;=4^G44.301
;;^UTILITY(U,$J,358.3,37011,2)
;;=^5003941
;;^UTILITY(U,$J,358.3,37012,0)
;;=G44.209^^107^1485^9
;;^UTILITY(U,$J,358.3,37012,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37012,1,3,0)
;;=3^Tension-Type Headache,Unspec,Not Intractable
;;^UTILITY(U,$J,358.3,37012,1,4,0)
;;=4^G44.209
;;^UTILITY(U,$J,358.3,37012,2)
;;=^5003936
;;^UTILITY(U,$J,358.3,37013,0)
;;=R51.0^^107^1485^3
;;^UTILITY(U,$J,358.3,37013,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37013,1,3,0)
;;=3^Headache w/ Orthostatic Component,NEC
;;^UTILITY(U,$J,358.3,37013,1,4,0)
;;=4^R51.0
;;^UTILITY(U,$J,358.3,37013,2)
;;=^5159305
;;^UTILITY(U,$J,358.3,37014,0)
;;=R51.9^^107^1485^4
;;^UTILITY(U,$J,358.3,37014,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37014,1,3,0)
;;=3^Headache,Unspec
;;^UTILITY(U,$J,358.3,37014,1,4,0)
;;=4^R51.9
;;^UTILITY(U,$J,358.3,37014,2)
;;=^5159306
;;^UTILITY(U,$J,358.3,37015,0)
;;=I30.0^^107^1486^5
;;^UTILITY(U,$J,358.3,37015,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37015,1,3,0)
;;=3^Idiopathic Pericarditis,Acute Nonspec
;;^UTILITY(U,$J,358.3,37015,1,4,0)
;;=4^I30.0
;;^UTILITY(U,$J,358.3,37015,2)
;;=^5007157
;;^UTILITY(U,$J,358.3,37016,0)
;;=I34.8^^107^1486^6
;;^UTILITY(U,$J,358.3,37016,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37016,1,3,0)
;;=3^Mitral Valve Disorders,Nonrheumatic Other
;;^UTILITY(U,$J,358.3,37016,1,4,0)
;;=4^I34.8
;;^UTILITY(U,$J,358.3,37016,2)
;;=^5007172
;;^UTILITY(U,$J,358.3,37017,0)
;;=I34.0^^107^1486^13
;;^UTILITY(U,$J,358.3,37017,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37017,1,3,0)
;;=3^Nonrheumatic Mitral Valve Insufficiency
;;^UTILITY(U,$J,358.3,37017,1,4,0)
;;=4^I34.0
;;^UTILITY(U,$J,358.3,37017,2)
;;=^5007169
;;^UTILITY(U,$J,358.3,37018,0)
;;=I34.9^^107^1486^12
;;^UTILITY(U,$J,358.3,37018,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37018,1,3,0)
;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
;;^UTILITY(U,$J,358.3,37018,1,4,0)
;;=4^I34.9
;;^UTILITY(U,$J,358.3,37018,2)
;;=^5007173
;;^UTILITY(U,$J,358.3,37019,0)
;;=I34.2^^107^1486^7
;;^UTILITY(U,$J,358.3,37019,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37019,1,3,0)
;;=3^Nonrhematic Mitral Valve Stenosis
;;^UTILITY(U,$J,358.3,37019,1,4,0)
;;=4^I34.2
;;^UTILITY(U,$J,358.3,37019,2)
;;=^5007171
;;^UTILITY(U,$J,358.3,37020,0)
;;=I35.0^^107^1486^10
;;^UTILITY(U,$J,358.3,37020,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37020,1,3,0)
;;=3^Nonrheumatic Aortic Valve Stenosis
;;^UTILITY(U,$J,358.3,37020,1,4,0)
;;=4^I35.0
;;^UTILITY(U,$J,358.3,37020,2)
;;=^5007174
;;^UTILITY(U,$J,358.3,37021,0)
;;=I35.1^^107^1486^9
;;^UTILITY(U,$J,358.3,37021,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37021,1,3,0)
;;=3^Nonrheumatic Aortic Valve Insufficiency
;;^UTILITY(U,$J,358.3,37021,1,4,0)
;;=4^I35.1
;;^UTILITY(U,$J,358.3,37021,2)
;;=^5007175
;;^UTILITY(U,$J,358.3,37022,0)
;;=I35.2^^107^1486^11
;;^UTILITY(U,$J,358.3,37022,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37022,1,3,0)
;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
;;^UTILITY(U,$J,358.3,37022,1,4,0)
;;=4^I35.2
;;^UTILITY(U,$J,358.3,37022,2)
;;=^5007176
;;^UTILITY(U,$J,358.3,37023,0)
;;=I35.9^^107^1486^8
;;^UTILITY(U,$J,358.3,37023,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37023,1,3,0)
;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
;;^UTILITY(U,$J,358.3,37023,1,4,0)
;;=4^I35.9
;;^UTILITY(U,$J,358.3,37023,2)
;;=^5007178
;;^UTILITY(U,$J,358.3,37024,0)
;;=I38.^^107^1486^4
;;^UTILITY(U,$J,358.3,37024,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37024,1,3,0)
;;=3^Endocarditis,Valve Unspec
;;^UTILITY(U,$J,358.3,37024,1,4,0)
;;=4^I38.
;;^UTILITY(U,$J,358.3,37024,2)
;;=^40327
;;^UTILITY(U,$J,358.3,37025,0)
;;=I05.0^^107^1486^18
;;^UTILITY(U,$J,358.3,37025,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37025,1,3,0)
;;=3^Rheumatic Mitral Stenosis
;;^UTILITY(U,$J,358.3,37025,1,4,0)
;;=4^I05.0
;;^UTILITY(U,$J,358.3,37025,2)
;;=^5007041
;;^UTILITY(U,$J,358.3,37026,0)
;;=I05.8^^107^1486^19
;;^UTILITY(U,$J,358.3,37026,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37026,1,3,0)
;;=3^Rheumatic Mitral Valve Disease NEC
;;^UTILITY(U,$J,358.3,37026,1,4,0)
;;=4^I05.8
;;^UTILITY(U,$J,358.3,37026,2)
;;=^5007043
;;^UTILITY(U,$J,358.3,37027,0)
;;=I05.9^^107^1486^20
;;^UTILITY(U,$J,358.3,37027,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37027,1,3,0)
;;=3^Rheumatic Mitral Valve Disease,Unspec
;;^UTILITY(U,$J,358.3,37027,1,4,0)
;;=4^I05.9
;;^UTILITY(U,$J,358.3,37027,2)
;;=^5007044
;;^UTILITY(U,$J,358.3,37028,0)
;;=I07.1^^107^1486^21
;;^UTILITY(U,$J,358.3,37028,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37028,1,3,0)
;;=3^Rheumatic Tricuspid Insufficiency
;;^UTILITY(U,$J,358.3,37028,1,4,0)
;;=4^I07.1
;;^UTILITY(U,$J,358.3,37028,2)
;;=^5007048
;;^UTILITY(U,$J,358.3,37029,0)
;;=I07.9^^107^1486^22
;;^UTILITY(U,$J,358.3,37029,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37029,1,3,0)
;;=3^Rheumatic Tricuspid Valve Disease,Unspec
;;^UTILITY(U,$J,358.3,37029,1,4,0)
;;=4^I07.9
;;^UTILITY(U,$J,358.3,37029,2)
;;=^5007051
;;^UTILITY(U,$J,358.3,37030,0)
;;=I08.0^^107^1486^16
;;^UTILITY(U,$J,358.3,37030,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37030,1,3,0)
;;=3^Rheumatic Disorders of Mitral & Aortic Valves
;;^UTILITY(U,$J,358.3,37030,1,4,0)
;;=4^I08.0
;;^UTILITY(U,$J,358.3,37030,2)
;;=^5007052
;;^UTILITY(U,$J,358.3,37031,0)
;;=I09.89^^107^1486^17
;;^UTILITY(U,$J,358.3,37031,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37031,1,3,0)
;;=3^Rheumatic Heart Diseases NEC
;;^UTILITY(U,$J,358.3,37031,1,4,0)
;;=4^I09.89
;;^UTILITY(U,$J,358.3,37031,2)
;;=^5007060
;;^UTILITY(U,$J,358.3,37032,0)
;;=I47.1^^107^1486^24
;;^UTILITY(U,$J,358.3,37032,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37032,1,3,0)
;;=3^Supraventricular Tachycardia
;;^UTILITY(U,$J,358.3,37032,1,4,0)
;;=4^I47.1
;;^UTILITY(U,$J,358.3,37032,2)
;;=^5007223
;;^UTILITY(U,$J,358.3,37033,0)
;;=I48.0^^107^1486^15
;;^UTILITY(U,$J,358.3,37033,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37033,1,3,0)
;;=3^Paroxysmal Atrial Fibrillation
;;^UTILITY(U,$J,358.3,37033,1,4,0)
;;=4^I48.0
;;^UTILITY(U,$J,358.3,37033,2)
;;=^90473
;;^UTILITY(U,$J,358.3,37034,0)
;;=I49.5^^107^1486^23
;;^UTILITY(U,$J,358.3,37034,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37034,1,3,0)
;;=3^Sick Sinus Syndrome
;;^UTILITY(U,$J,358.3,37034,1,4,0)
;;=4^I49.5
;;^UTILITY(U,$J,358.3,37034,2)
;;=^110404
;;^UTILITY(U,$J,358.3,37035,0)
;;=I49.8^^107^1486^3
;;^UTILITY(U,$J,358.3,37035,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37035,1,3,0)
;;=3^Cardiac Arrhythmias
;;^UTILITY(U,$J,358.3,37035,1,4,0)
;;=4^I49.8
;;^UTILITY(U,$J,358.3,37035,2)
;;=^5007236
;;^UTILITY(U,$J,358.3,37036,0)
;;=I49.9^^107^1486^2
;;^UTILITY(U,$J,358.3,37036,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37036,1,3,0)
;;=3^Cardiac Arrhythmia,Unspec
;;^UTILITY(U,$J,358.3,37036,1,4,0)
;;=4^I49.9
;;^UTILITY(U,$J,358.3,37036,2)
;;=^5007237
;;^UTILITY(U,$J,358.3,37037,0)
;;=R00.1^^107^1486^1
;;^UTILITY(U,$J,358.3,37037,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37037,1,3,0)
;;=3^Bradycardia,Unspec
;;^UTILITY(U,$J,358.3,37037,1,4,0)
;;=4^R00.1
;;^UTILITY(U,$J,358.3,37037,2)
;;=^5019164
;;^UTILITY(U,$J,358.3,37038,0)
;;=I34.1^^107^1486^14
;;^UTILITY(U,$J,358.3,37038,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37038,1,3,0)
;;=3^Nonrheumatic Mitral Valve Prolapse
;;^UTILITY(U,$J,358.3,37038,1,4,0)
;;=4^I34.1
;;^UTILITY(U,$J,358.3,37038,2)
;;=^5007170
;;^UTILITY(U,$J,358.3,37039,0)
;;=D68.4^^107^1487^1
;;^UTILITY(U,$J,358.3,37039,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37039,1,3,0)
;;=3^Acquired Coagulation Factor Deficiency
;;^UTILITY(U,$J,358.3,37039,1,4,0)
;;=4^D68.4
;;^UTILITY(U,$J,358.3,37039,2)
;;=^2235
;;^UTILITY(U,$J,358.3,37040,0)
;;=D59.9^^107^1487^2
;;^UTILITY(U,$J,358.3,37040,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37040,1,3,0)
;;=3^Acquired Hemolytic Anemia,Unspec
;;^UTILITY(U,$J,358.3,37040,1,4,0)
;;=4^D59.9
;;^UTILITY(U,$J,358.3,37040,2)
;;=^5002330
;;^UTILITY(U,$J,358.3,37041,0)
;;=C91.00^^107^1487^5
;;^UTILITY(U,$J,358.3,37041,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37041,1,3,0)
;;=3^Acute Lymphoblastic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,37041,1,4,0)
;;=4^C91.00
;;^UTILITY(U,$J,358.3,37041,2)
;;=^5001762
;;^UTILITY(U,$J,358.3,37042,0)
;;=C91.01^^107^1487^4
;;^UTILITY(U,$J,358.3,37042,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37042,1,3,0)
;;=3^Acute Lymphoblastic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,37042,1,4,0)
;;=4^C91.01
;;^UTILITY(U,$J,358.3,37042,2)
;;=^5001763
;;^UTILITY(U,$J,358.3,37043,0)
;;=C92.01^^107^1487^7
;;^UTILITY(U,$J,358.3,37043,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37043,1,3,0)
;;=3^Acute Myeloblastic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,37043,1,4,0)
;;=4^C92.01
;;^UTILITY(U,$J,358.3,37043,2)
;;=^5001790
;;^UTILITY(U,$J,358.3,37044,0)
;;=C92.00^^107^1487^8
;;^UTILITY(U,$J,358.3,37044,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37044,1,3,0)
;;=3^Acute Myeloblastic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,37044,1,4,0)
;;=4^C92.00
;;^UTILITY(U,$J,358.3,37044,2)
;;=^5001789
;;^UTILITY(U,$J,358.3,37045,0)
;;=C92.61^^107^1487^9
;;^UTILITY(U,$J,358.3,37045,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37045,1,3,0)
;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
;;^UTILITY(U,$J,358.3,37045,1,4,0)
;;=4^C92.61
;;^UTILITY(U,$J,358.3,37045,2)
;;=^5001808
;;^UTILITY(U,$J,358.3,37046,0)
;;=C92.60^^107^1487^10
;;^UTILITY(U,$J,358.3,37046,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37046,1,3,0)
;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
;;^UTILITY(U,$J,358.3,37046,1,4,0)
;;=4^C92.60
;;^UTILITY(U,$J,358.3,37046,2)
;;=^5001807
;;^UTILITY(U,$J,358.3,37047,0)
;;=C92.A1^^107^1487^11
;;^UTILITY(U,$J,358.3,37047,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37047,1,3,0)
;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
;;^UTILITY(U,$J,358.3,37047,1,4,0)
;;=4^C92.A1
;;^UTILITY(U,$J,358.3,37047,2)
;;=^5001814
;;^UTILITY(U,$J,358.3,37048,0)
;;=C92.A0^^107^1487^12
;;^UTILITY(U,$J,358.3,37048,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37048,1,3,0)
;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
;;^UTILITY(U,$J,358.3,37048,1,4,0)
;;=4^C92.A0
;;^UTILITY(U,$J,358.3,37048,2)
;;=^5001813
;;^UTILITY(U,$J,358.3,37049,0)
;;=C92.51^^107^1487^13
;;^UTILITY(U,$J,358.3,37049,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37049,1,3,0)
;;=3^Acute Myelomonocytic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,37049,1,4,0)
;;=4^C92.51
;;^UTILITY(U,$J,358.3,37049,2)
;;=^5001805
;;^UTILITY(U,$J,358.3,37050,0)
;;=C92.50^^107^1487^14
;;^UTILITY(U,$J,358.3,37050,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37050,1,3,0)
;;=3^Acute Myelomonocytic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,37050,1,4,0)
;;=4^C92.50
;;^UTILITY(U,$J,358.3,37050,2)
;;=^5001804
;;^UTILITY(U,$J,358.3,37051,0)
;;=C94.40^^107^1487^17
;;^UTILITY(U,$J,358.3,37051,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37051,1,3,0)
;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
;;^UTILITY(U,$J,358.3,37051,1,4,0)
;;=4^C94.40
;;^UTILITY(U,$J,358.3,37051,2)
;;=^5001843
;;^UTILITY(U,$J,358.3,37052,0)
;;=C94.42^^107^1487^15
;;^UTILITY(U,$J,358.3,37052,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37052,1,3,0)
;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
;;^UTILITY(U,$J,358.3,37052,1,4,0)
;;=4^C94.42
;;^UTILITY(U,$J,358.3,37052,2)
;;=^5001845
;;^UTILITY(U,$J,358.3,37053,0)
;;=C94.41^^107^1487^16
;;^UTILITY(U,$J,358.3,37053,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37053,1,3,0)
;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
;;^UTILITY(U,$J,358.3,37053,1,4,0)
;;=4^C94.41
;;^UTILITY(U,$J,358.3,37053,2)
;;=^5001844
;;^UTILITY(U,$J,358.3,37054,0)
;;=D62.^^107^1487^18
;;^UTILITY(U,$J,358.3,37054,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37054,1,3,0)
;;=3^Acute Posthemorrhagic Anemia
;;^UTILITY(U,$J,358.3,37054,1,4,0)
;;=4^D62.
;;^UTILITY(U,$J,358.3,37054,2)
;;=^267986
;;^UTILITY(U,$J,358.3,37055,0)
;;=C92.41^^107^1487^19
;;^UTILITY(U,$J,358.3,37055,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37055,1,3,0)
;;=3^Acute Promyelocytic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,37055,1,4,0)
;;=4^C92.41
;;^UTILITY(U,$J,358.3,37055,2)
;;=^5001802
;;^UTILITY(U,$J,358.3,37056,0)
;;=C92.40^^107^1487^20
;;^UTILITY(U,$J,358.3,37056,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37056,1,3,0)
;;=3^Acute Promyelocytic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,37056,1,4,0)
;;=4^C92.40
;;^UTILITY(U,$J,358.3,37056,2)
;;=^5001801
;;^UTILITY(U,$J,358.3,37057,0)
;;=D56.0^^107^1487^21
;;^UTILITY(U,$J,358.3,37057,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37057,1,3,0)
;;=3^Alpha Thalassemia
;;^UTILITY(U,$J,358.3,37057,1,4,0)
;;=4^D56.0
;;^UTILITY(U,$J,358.3,37057,2)
;;=^340494
;;^UTILITY(U,$J,358.3,37058,0)
;;=D63.1^^107^1487^23
;;^UTILITY(U,$J,358.3,37058,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37058,1,3,0)
;;=3^Anemia in Chronic Kidney Disease
;;^UTILITY(U,$J,358.3,37058,1,4,0)
;;=4^D63.1
;;^UTILITY(U,$J,358.3,37058,2)
;;=^332908
;;^UTILITY(U,$J,358.3,37059,0)
;;=D63.0^^107^1487^24
;;^UTILITY(U,$J,358.3,37059,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37059,1,3,0)
;;=3^Anemia in Neoplastic Disease
;;^UTILITY(U,$J,358.3,37059,1,4,0)
;;=4^D63.0
;;^UTILITY(U,$J,358.3,37059,2)
;;=^321978
;;^UTILITY(U,$J,358.3,37060,0)
;;=D63.8^^107^1487^22
;;^UTILITY(U,$J,358.3,37060,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37060,1,3,0)
;;=3^Anemia in Chronic Diseases Classified Elsewhere
;;^UTILITY(U,$J,358.3,37060,1,4,0)
;;=4^D63.8
;;^UTILITY(U,$J,358.3,37060,2)
;;=^5002343
;;^UTILITY(U,$J,358.3,37061,0)
;;=C22.3^^107^1487^27
;;^UTILITY(U,$J,358.3,37061,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37061,1,3,0)
;;=3^Angiosarcoma of Liver
;;^UTILITY(U,$J,358.3,37061,1,4,0)
;;=4^C22.3
;;^UTILITY(U,$J,358.3,37061,2)
;;=^5000936
;;^UTILITY(U,$J,358.3,37062,0)
;;=D61.9^^107^1487^28
;;^UTILITY(U,$J,358.3,37062,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37062,1,3,0)
;;=3^Aplastic Anemia,Unspec
;;^UTILITY(U,$J,358.3,37062,1,4,0)
;;=4^D61.9
;;^UTILITY(U,$J,358.3,37062,2)
;;=^5002342
;;^UTILITY(U,$J,358.3,37063,0)
;;=D56.1^^107^1487^34
;;^UTILITY(U,$J,358.3,37063,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37063,1,3,0)
;;=3^Beta Thalassemia
;;^UTILITY(U,$J,358.3,37063,1,4,0)
;;=4^D56.1
;;^UTILITY(U,$J,358.3,37063,2)
;;=^340495
;;^UTILITY(U,$J,358.3,37064,0)
;;=C83.79^^107^1487^36
;;^UTILITY(U,$J,358.3,37064,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,37064,1,3,0)
;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,37064,1,4,0)
;;=4^C83.79
;;^UTILITY(U,$J,358.3,37064,2)
;;=^5001600
;;^UTILITY(U,$J,358.3,37065,0)
;;=C83.70^^107^1487^37
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0ES 19748 printed Apr 09, 2024@20:56:17 Page 2
IBDEI0ES ; ; 03-MAY-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,36997,1,4,0)
+2 ;;=4^N50.812
+3 ;;^UTILITY(U,$J,358.3,36997,2)
+4 ;;=^5138928
+5 ;;^UTILITY(U,$J,358.3,36998,0)
+6 ;;=N50.811^^107^1484^109
+7 ;;^UTILITY(U,$J,358.3,36998,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,36998,1,3,0)
+10 ;;=3^Testicular Pain,Right Side
+11 ;;^UTILITY(U,$J,358.3,36998,1,4,0)
+12 ;;=4^N50.811
+13 ;;^UTILITY(U,$J,358.3,36998,2)
+14 ;;=^5138927
+15 ;;^UTILITY(U,$J,358.3,36999,0)
+16 ;;=N35.919^^107^1484^114
+17 ;;^UTILITY(U,$J,358.3,36999,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,36999,1,3,0)
+20 ;;=3^Urethral Stricture,NOS,Male
+21 ;;^UTILITY(U,$J,358.3,36999,1,4,0)
+22 ;;=4^N35.919
+23 ;;^UTILITY(U,$J,358.3,36999,2)
+24 ;;=^5157412
+25 ;;^UTILITY(U,$J,358.3,37000,0)
+26 ;;=N35.92^^107^1484^113
+27 ;;^UTILITY(U,$J,358.3,37000,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,37000,1,3,0)
+30 ;;=3^Urethral Stricture,NOS,Female
+31 ;;^UTILITY(U,$J,358.3,37000,1,4,0)
+32 ;;=4^N35.92
+33 ;;^UTILITY(U,$J,358.3,37000,2)
+34 ;;=^5157413
+35 ;;^UTILITY(U,$J,358.3,37001,0)
+36 ;;=R82.81^^107^1484^101
+37 ;;^UTILITY(U,$J,358.3,37001,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,37001,1,3,0)
+40 ;;=3^Pyuria
+41 ;;^UTILITY(U,$J,358.3,37001,1,4,0)
+42 ;;=4^R82.81
+43 ;;^UTILITY(U,$J,358.3,37001,2)
+44 ;;=^101879
+45 ;;^UTILITY(U,$J,358.3,37002,0)
+46 ;;=N18.30^^107^1484^17
+47 ;;^UTILITY(U,$J,358.3,37002,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,37002,1,3,0)
+50 ;;=3^Chronic Kidney Disease,Stage 3 Unspec
+51 ;;^UTILITY(U,$J,358.3,37002,1,4,0)
+52 ;;=4^N18.30
+53 ;;^UTILITY(U,$J,358.3,37002,2)
+54 ;;=^5159286
+55 ;;^UTILITY(U,$J,358.3,37003,0)
+56 ;;=N18.31^^107^1484^18
+57 ;;^UTILITY(U,$J,358.3,37003,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,37003,1,3,0)
+60 ;;=3^Chronic Kidney Disease,Stage 3a
+61 ;;^UTILITY(U,$J,358.3,37003,1,4,0)
+62 ;;=4^N18.31
+63 ;;^UTILITY(U,$J,358.3,37003,2)
+64 ;;=^5159287
+65 ;;^UTILITY(U,$J,358.3,37004,0)
+66 ;;=N18.32^^107^1484^19
+67 ;;^UTILITY(U,$J,358.3,37004,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,37004,1,3,0)
+70 ;;=3^Chronic Kidney Disease,Stage 3b
+71 ;;^UTILITY(U,$J,358.3,37004,1,4,0)
+72 ;;=4^N18.32
+73 ;;^UTILITY(U,$J,358.3,37004,2)
+74 ;;=^5159288
+75 ;;^UTILITY(U,$J,358.3,37005,0)
+76 ;;=G44.1^^107^1485^10
+77 ;;^UTILITY(U,$J,358.3,37005,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,37005,1,3,0)
+80 ;;=3^Vascular Headache NEC
+81 ;;^UTILITY(U,$J,358.3,37005,1,4,0)
+82 ;;=4^G44.1
+83 ;;^UTILITY(U,$J,358.3,37005,2)
+84 ;;=^5003934
+85 ;;^UTILITY(U,$J,358.3,37006,0)
+86 ;;=G43.909^^107^1485^6
+87 ;;^UTILITY(U,$J,358.3,37006,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,37006,1,3,0)
+90 ;;=3^Migraine,Unspec,Not Intractable
+91 ;;^UTILITY(U,$J,358.3,37006,1,4,0)
+92 ;;=4^G43.909
+93 ;;^UTILITY(U,$J,358.3,37006,2)
+94 ;;=^5003909
+95 ;;^UTILITY(U,$J,358.3,37007,0)
+96 ;;=G44.009^^107^1485^1
+97 ;;^UTILITY(U,$J,358.3,37007,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,37007,1,3,0)
+100 ;;=3^Cluster Headache,Unspec,Not Intractable
+101 ;;^UTILITY(U,$J,358.3,37007,1,4,0)
+102 ;;=4^G44.009
+103 ;;^UTILITY(U,$J,358.3,37007,2)
+104 ;;=^5003921
+105 ;;^UTILITY(U,$J,358.3,37008,0)
+106 ;;=G44.40^^107^1485^5
+107 ;;^UTILITY(U,$J,358.3,37008,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,37008,1,3,0)
+110 ;;=3^Medication Overuse Headache,Not Intractable
+111 ;;^UTILITY(U,$J,358.3,37008,1,4,0)
+112 ;;=4^G44.40
+113 ;;^UTILITY(U,$J,358.3,37008,2)
+114 ;;=^5003947
+115 ;;^UTILITY(U,$J,358.3,37009,0)
+116 ;;=G44.89^^107^1485^2
+117 ;;^UTILITY(U,$J,358.3,37009,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,37009,1,3,0)
+120 ;;=3^Headache Syndrome NEC
+121 ;;^UTILITY(U,$J,358.3,37009,1,4,0)
+122 ;;=4^G44.89
+123 ;;^UTILITY(U,$J,358.3,37009,2)
+124 ;;=^5003954
+125 ;;^UTILITY(U,$J,358.3,37010,0)
+126 ;;=G44.84^^107^1485^8
+127 ;;^UTILITY(U,$J,358.3,37010,1,0)
+128 ;;=^358.31IA^4^2
+129 ;;^UTILITY(U,$J,358.3,37010,1,3,0)
+130 ;;=3^Primary Exertional Headache
+131 ;;^UTILITY(U,$J,358.3,37010,1,4,0)
+132 ;;=4^G44.84
+133 ;;^UTILITY(U,$J,358.3,37010,2)
+134 ;;=^336563
+135 ;;^UTILITY(U,$J,358.3,37011,0)
+136 ;;=G44.301^^107^1485^7
+137 ;;^UTILITY(U,$J,358.3,37011,1,0)
+138 ;;=^358.31IA^4^2
+139 ;;^UTILITY(U,$J,358.3,37011,1,3,0)
+140 ;;=3^Post-Traumatic Headache,Unspec,Intractable
+141 ;;^UTILITY(U,$J,358.3,37011,1,4,0)
+142 ;;=4^G44.301
+143 ;;^UTILITY(U,$J,358.3,37011,2)
+144 ;;=^5003941
+145 ;;^UTILITY(U,$J,358.3,37012,0)
+146 ;;=G44.209^^107^1485^9
+147 ;;^UTILITY(U,$J,358.3,37012,1,0)
+148 ;;=^358.31IA^4^2
+149 ;;^UTILITY(U,$J,358.3,37012,1,3,0)
+150 ;;=3^Tension-Type Headache,Unspec,Not Intractable
+151 ;;^UTILITY(U,$J,358.3,37012,1,4,0)
+152 ;;=4^G44.209
+153 ;;^UTILITY(U,$J,358.3,37012,2)
+154 ;;=^5003936
+155 ;;^UTILITY(U,$J,358.3,37013,0)
+156 ;;=R51.0^^107^1485^3
+157 ;;^UTILITY(U,$J,358.3,37013,1,0)
+158 ;;=^358.31IA^4^2
+159 ;;^UTILITY(U,$J,358.3,37013,1,3,0)
+160 ;;=3^Headache w/ Orthostatic Component,NEC
+161 ;;^UTILITY(U,$J,358.3,37013,1,4,0)
+162 ;;=4^R51.0
+163 ;;^UTILITY(U,$J,358.3,37013,2)
+164 ;;=^5159305
+165 ;;^UTILITY(U,$J,358.3,37014,0)
+166 ;;=R51.9^^107^1485^4
+167 ;;^UTILITY(U,$J,358.3,37014,1,0)
+168 ;;=^358.31IA^4^2
+169 ;;^UTILITY(U,$J,358.3,37014,1,3,0)
+170 ;;=3^Headache,Unspec
+171 ;;^UTILITY(U,$J,358.3,37014,1,4,0)
+172 ;;=4^R51.9
+173 ;;^UTILITY(U,$J,358.3,37014,2)
+174 ;;=^5159306
+175 ;;^UTILITY(U,$J,358.3,37015,0)
+176 ;;=I30.0^^107^1486^5
+177 ;;^UTILITY(U,$J,358.3,37015,1,0)
+178 ;;=^358.31IA^4^2
+179 ;;^UTILITY(U,$J,358.3,37015,1,3,0)
+180 ;;=3^Idiopathic Pericarditis,Acute Nonspec
+181 ;;^UTILITY(U,$J,358.3,37015,1,4,0)
+182 ;;=4^I30.0
+183 ;;^UTILITY(U,$J,358.3,37015,2)
+184 ;;=^5007157
+185 ;;^UTILITY(U,$J,358.3,37016,0)
+186 ;;=I34.8^^107^1486^6
+187 ;;^UTILITY(U,$J,358.3,37016,1,0)
+188 ;;=^358.31IA^4^2
+189 ;;^UTILITY(U,$J,358.3,37016,1,3,0)
+190 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
+191 ;;^UTILITY(U,$J,358.3,37016,1,4,0)
+192 ;;=4^I34.8
+193 ;;^UTILITY(U,$J,358.3,37016,2)
+194 ;;=^5007172
+195 ;;^UTILITY(U,$J,358.3,37017,0)
+196 ;;=I34.0^^107^1486^13
+197 ;;^UTILITY(U,$J,358.3,37017,1,0)
+198 ;;=^358.31IA^4^2
+199 ;;^UTILITY(U,$J,358.3,37017,1,3,0)
+200 ;;=3^Nonrheumatic Mitral Valve Insufficiency
+201 ;;^UTILITY(U,$J,358.3,37017,1,4,0)
+202 ;;=4^I34.0
+203 ;;^UTILITY(U,$J,358.3,37017,2)
+204 ;;=^5007169
+205 ;;^UTILITY(U,$J,358.3,37018,0)
+206 ;;=I34.9^^107^1486^12
+207 ;;^UTILITY(U,$J,358.3,37018,1,0)
+208 ;;=^358.31IA^4^2
+209 ;;^UTILITY(U,$J,358.3,37018,1,3,0)
+210 ;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
+211 ;;^UTILITY(U,$J,358.3,37018,1,4,0)
+212 ;;=4^I34.9
+213 ;;^UTILITY(U,$J,358.3,37018,2)
+214 ;;=^5007173
+215 ;;^UTILITY(U,$J,358.3,37019,0)
+216 ;;=I34.2^^107^1486^7
+217 ;;^UTILITY(U,$J,358.3,37019,1,0)
+218 ;;=^358.31IA^4^2
+219 ;;^UTILITY(U,$J,358.3,37019,1,3,0)
+220 ;;=3^Nonrhematic Mitral Valve Stenosis
+221 ;;^UTILITY(U,$J,358.3,37019,1,4,0)
+222 ;;=4^I34.2
+223 ;;^UTILITY(U,$J,358.3,37019,2)
+224 ;;=^5007171
+225 ;;^UTILITY(U,$J,358.3,37020,0)
+226 ;;=I35.0^^107^1486^10
+227 ;;^UTILITY(U,$J,358.3,37020,1,0)
+228 ;;=^358.31IA^4^2
+229 ;;^UTILITY(U,$J,358.3,37020,1,3,0)
+230 ;;=3^Nonrheumatic Aortic Valve Stenosis
+231 ;;^UTILITY(U,$J,358.3,37020,1,4,0)
+232 ;;=4^I35.0
+233 ;;^UTILITY(U,$J,358.3,37020,2)
+234 ;;=^5007174
+235 ;;^UTILITY(U,$J,358.3,37021,0)
+236 ;;=I35.1^^107^1486^9
+237 ;;^UTILITY(U,$J,358.3,37021,1,0)
+238 ;;=^358.31IA^4^2
+239 ;;^UTILITY(U,$J,358.3,37021,1,3,0)
+240 ;;=3^Nonrheumatic Aortic Valve Insufficiency
+241 ;;^UTILITY(U,$J,358.3,37021,1,4,0)
+242 ;;=4^I35.1
+243 ;;^UTILITY(U,$J,358.3,37021,2)
+244 ;;=^5007175
+245 ;;^UTILITY(U,$J,358.3,37022,0)
+246 ;;=I35.2^^107^1486^11
+247 ;;^UTILITY(U,$J,358.3,37022,1,0)
+248 ;;=^358.31IA^4^2
+249 ;;^UTILITY(U,$J,358.3,37022,1,3,0)
+250 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
+251 ;;^UTILITY(U,$J,358.3,37022,1,4,0)
+252 ;;=4^I35.2
+253 ;;^UTILITY(U,$J,358.3,37022,2)
+254 ;;=^5007176
+255 ;;^UTILITY(U,$J,358.3,37023,0)
+256 ;;=I35.9^^107^1486^8
+257 ;;^UTILITY(U,$J,358.3,37023,1,0)
+258 ;;=^358.31IA^4^2
+259 ;;^UTILITY(U,$J,358.3,37023,1,3,0)
+260 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
+261 ;;^UTILITY(U,$J,358.3,37023,1,4,0)
+262 ;;=4^I35.9
+263 ;;^UTILITY(U,$J,358.3,37023,2)
+264 ;;=^5007178
+265 ;;^UTILITY(U,$J,358.3,37024,0)
+266 ;;=I38.^^107^1486^4
+267 ;;^UTILITY(U,$J,358.3,37024,1,0)
+268 ;;=^358.31IA^4^2
+269 ;;^UTILITY(U,$J,358.3,37024,1,3,0)
+270 ;;=3^Endocarditis,Valve Unspec
+271 ;;^UTILITY(U,$J,358.3,37024,1,4,0)
+272 ;;=4^I38.
+273 ;;^UTILITY(U,$J,358.3,37024,2)
+274 ;;=^40327
+275 ;;^UTILITY(U,$J,358.3,37025,0)
+276 ;;=I05.0^^107^1486^18
+277 ;;^UTILITY(U,$J,358.3,37025,1,0)
+278 ;;=^358.31IA^4^2
+279 ;;^UTILITY(U,$J,358.3,37025,1,3,0)
+280 ;;=3^Rheumatic Mitral Stenosis
+281 ;;^UTILITY(U,$J,358.3,37025,1,4,0)
+282 ;;=4^I05.0
+283 ;;^UTILITY(U,$J,358.3,37025,2)
+284 ;;=^5007041
+285 ;;^UTILITY(U,$J,358.3,37026,0)
+286 ;;=I05.8^^107^1486^19
+287 ;;^UTILITY(U,$J,358.3,37026,1,0)
+288 ;;=^358.31IA^4^2
+289 ;;^UTILITY(U,$J,358.3,37026,1,3,0)
+290 ;;=3^Rheumatic Mitral Valve Disease NEC
+291 ;;^UTILITY(U,$J,358.3,37026,1,4,0)
+292 ;;=4^I05.8
+293 ;;^UTILITY(U,$J,358.3,37026,2)
+294 ;;=^5007043
+295 ;;^UTILITY(U,$J,358.3,37027,0)
+296 ;;=I05.9^^107^1486^20
+297 ;;^UTILITY(U,$J,358.3,37027,1,0)
+298 ;;=^358.31IA^4^2
+299 ;;^UTILITY(U,$J,358.3,37027,1,3,0)
+300 ;;=3^Rheumatic Mitral Valve Disease,Unspec
+301 ;;^UTILITY(U,$J,358.3,37027,1,4,0)
+302 ;;=4^I05.9
+303 ;;^UTILITY(U,$J,358.3,37027,2)
+304 ;;=^5007044
+305 ;;^UTILITY(U,$J,358.3,37028,0)
+306 ;;=I07.1^^107^1486^21
+307 ;;^UTILITY(U,$J,358.3,37028,1,0)
+308 ;;=^358.31IA^4^2
+309 ;;^UTILITY(U,$J,358.3,37028,1,3,0)
+310 ;;=3^Rheumatic Tricuspid Insufficiency
+311 ;;^UTILITY(U,$J,358.3,37028,1,4,0)
+312 ;;=4^I07.1
+313 ;;^UTILITY(U,$J,358.3,37028,2)
+314 ;;=^5007048
+315 ;;^UTILITY(U,$J,358.3,37029,0)
+316 ;;=I07.9^^107^1486^22
+317 ;;^UTILITY(U,$J,358.3,37029,1,0)
+318 ;;=^358.31IA^4^2
+319 ;;^UTILITY(U,$J,358.3,37029,1,3,0)
+320 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
+321 ;;^UTILITY(U,$J,358.3,37029,1,4,0)
+322 ;;=4^I07.9
+323 ;;^UTILITY(U,$J,358.3,37029,2)
+324 ;;=^5007051
+325 ;;^UTILITY(U,$J,358.3,37030,0)
+326 ;;=I08.0^^107^1486^16
+327 ;;^UTILITY(U,$J,358.3,37030,1,0)
+328 ;;=^358.31IA^4^2
+329 ;;^UTILITY(U,$J,358.3,37030,1,3,0)
+330 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
+331 ;;^UTILITY(U,$J,358.3,37030,1,4,0)
+332 ;;=4^I08.0
+333 ;;^UTILITY(U,$J,358.3,37030,2)
+334 ;;=^5007052
+335 ;;^UTILITY(U,$J,358.3,37031,0)
+336 ;;=I09.89^^107^1486^17
+337 ;;^UTILITY(U,$J,358.3,37031,1,0)
+338 ;;=^358.31IA^4^2
+339 ;;^UTILITY(U,$J,358.3,37031,1,3,0)
+340 ;;=3^Rheumatic Heart Diseases NEC
+341 ;;^UTILITY(U,$J,358.3,37031,1,4,0)
+342 ;;=4^I09.89
+343 ;;^UTILITY(U,$J,358.3,37031,2)
+344 ;;=^5007060
+345 ;;^UTILITY(U,$J,358.3,37032,0)
+346 ;;=I47.1^^107^1486^24
+347 ;;^UTILITY(U,$J,358.3,37032,1,0)
+348 ;;=^358.31IA^4^2
+349 ;;^UTILITY(U,$J,358.3,37032,1,3,0)
+350 ;;=3^Supraventricular Tachycardia
+351 ;;^UTILITY(U,$J,358.3,37032,1,4,0)
+352 ;;=4^I47.1
+353 ;;^UTILITY(U,$J,358.3,37032,2)
+354 ;;=^5007223
+355 ;;^UTILITY(U,$J,358.3,37033,0)
+356 ;;=I48.0^^107^1486^15
+357 ;;^UTILITY(U,$J,358.3,37033,1,0)
+358 ;;=^358.31IA^4^2
+359 ;;^UTILITY(U,$J,358.3,37033,1,3,0)
+360 ;;=3^Paroxysmal Atrial Fibrillation
+361 ;;^UTILITY(U,$J,358.3,37033,1,4,0)
+362 ;;=4^I48.0
+363 ;;^UTILITY(U,$J,358.3,37033,2)
+364 ;;=^90473
+365 ;;^UTILITY(U,$J,358.3,37034,0)
+366 ;;=I49.5^^107^1486^23
+367 ;;^UTILITY(U,$J,358.3,37034,1,0)
+368 ;;=^358.31IA^4^2
+369 ;;^UTILITY(U,$J,358.3,37034,1,3,0)
+370 ;;=3^Sick Sinus Syndrome
+371 ;;^UTILITY(U,$J,358.3,37034,1,4,0)
+372 ;;=4^I49.5
+373 ;;^UTILITY(U,$J,358.3,37034,2)
+374 ;;=^110404
+375 ;;^UTILITY(U,$J,358.3,37035,0)
+376 ;;=I49.8^^107^1486^3
+377 ;;^UTILITY(U,$J,358.3,37035,1,0)
+378 ;;=^358.31IA^4^2
+379 ;;^UTILITY(U,$J,358.3,37035,1,3,0)
+380 ;;=3^Cardiac Arrhythmias
+381 ;;^UTILITY(U,$J,358.3,37035,1,4,0)
+382 ;;=4^I49.8
+383 ;;^UTILITY(U,$J,358.3,37035,2)
+384 ;;=^5007236
+385 ;;^UTILITY(U,$J,358.3,37036,0)
+386 ;;=I49.9^^107^1486^2
+387 ;;^UTILITY(U,$J,358.3,37036,1,0)
+388 ;;=^358.31IA^4^2
+389 ;;^UTILITY(U,$J,358.3,37036,1,3,0)
+390 ;;=3^Cardiac Arrhythmia,Unspec
+391 ;;^UTILITY(U,$J,358.3,37036,1,4,0)
+392 ;;=4^I49.9
+393 ;;^UTILITY(U,$J,358.3,37036,2)
+394 ;;=^5007237
+395 ;;^UTILITY(U,$J,358.3,37037,0)
+396 ;;=R00.1^^107^1486^1
+397 ;;^UTILITY(U,$J,358.3,37037,1,0)
+398 ;;=^358.31IA^4^2
+399 ;;^UTILITY(U,$J,358.3,37037,1,3,0)
+400 ;;=3^Bradycardia,Unspec
+401 ;;^UTILITY(U,$J,358.3,37037,1,4,0)
+402 ;;=4^R00.1
+403 ;;^UTILITY(U,$J,358.3,37037,2)
+404 ;;=^5019164
+405 ;;^UTILITY(U,$J,358.3,37038,0)
+406 ;;=I34.1^^107^1486^14
+407 ;;^UTILITY(U,$J,358.3,37038,1,0)
+408 ;;=^358.31IA^4^2
+409 ;;^UTILITY(U,$J,358.3,37038,1,3,0)
+410 ;;=3^Nonrheumatic Mitral Valve Prolapse
+411 ;;^UTILITY(U,$J,358.3,37038,1,4,0)
+412 ;;=4^I34.1
+413 ;;^UTILITY(U,$J,358.3,37038,2)
+414 ;;=^5007170
+415 ;;^UTILITY(U,$J,358.3,37039,0)
+416 ;;=D68.4^^107^1487^1
+417 ;;^UTILITY(U,$J,358.3,37039,1,0)
+418 ;;=^358.31IA^4^2
+419 ;;^UTILITY(U,$J,358.3,37039,1,3,0)
+420 ;;=3^Acquired Coagulation Factor Deficiency
+421 ;;^UTILITY(U,$J,358.3,37039,1,4,0)
+422 ;;=4^D68.4
+423 ;;^UTILITY(U,$J,358.3,37039,2)
+424 ;;=^2235
+425 ;;^UTILITY(U,$J,358.3,37040,0)
+426 ;;=D59.9^^107^1487^2
+427 ;;^UTILITY(U,$J,358.3,37040,1,0)
+428 ;;=^358.31IA^4^2
+429 ;;^UTILITY(U,$J,358.3,37040,1,3,0)
+430 ;;=3^Acquired Hemolytic Anemia,Unspec
+431 ;;^UTILITY(U,$J,358.3,37040,1,4,0)
+432 ;;=4^D59.9
+433 ;;^UTILITY(U,$J,358.3,37040,2)
+434 ;;=^5002330
+435 ;;^UTILITY(U,$J,358.3,37041,0)
+436 ;;=C91.00^^107^1487^5
+437 ;;^UTILITY(U,$J,358.3,37041,1,0)
+438 ;;=^358.31IA^4^2
+439 ;;^UTILITY(U,$J,358.3,37041,1,3,0)
+440 ;;=3^Acute Lymphoblastic Leukemia,Not in Remission
+441 ;;^UTILITY(U,$J,358.3,37041,1,4,0)
+442 ;;=4^C91.00
+443 ;;^UTILITY(U,$J,358.3,37041,2)
+444 ;;=^5001762
+445 ;;^UTILITY(U,$J,358.3,37042,0)
+446 ;;=C91.01^^107^1487^4
+447 ;;^UTILITY(U,$J,358.3,37042,1,0)
+448 ;;=^358.31IA^4^2
+449 ;;^UTILITY(U,$J,358.3,37042,1,3,0)
+450 ;;=3^Acute Lymphoblastic Leukemia,In Remission
+451 ;;^UTILITY(U,$J,358.3,37042,1,4,0)
+452 ;;=4^C91.01
+453 ;;^UTILITY(U,$J,358.3,37042,2)
+454 ;;=^5001763
+455 ;;^UTILITY(U,$J,358.3,37043,0)
+456 ;;=C92.01^^107^1487^7
+457 ;;^UTILITY(U,$J,358.3,37043,1,0)
+458 ;;=^358.31IA^4^2
+459 ;;^UTILITY(U,$J,358.3,37043,1,3,0)
+460 ;;=3^Acute Myeloblastic Leukemia,In Remission
+461 ;;^UTILITY(U,$J,358.3,37043,1,4,0)
+462 ;;=4^C92.01
+463 ;;^UTILITY(U,$J,358.3,37043,2)
+464 ;;=^5001790
+465 ;;^UTILITY(U,$J,358.3,37044,0)
+466 ;;=C92.00^^107^1487^8
+467 ;;^UTILITY(U,$J,358.3,37044,1,0)
+468 ;;=^358.31IA^4^2
+469 ;;^UTILITY(U,$J,358.3,37044,1,3,0)
+470 ;;=3^Acute Myeloblastic Leukemia,Not in Remission
+471 ;;^UTILITY(U,$J,358.3,37044,1,4,0)
+472 ;;=4^C92.00
+473 ;;^UTILITY(U,$J,358.3,37044,2)
+474 ;;=^5001789
+475 ;;^UTILITY(U,$J,358.3,37045,0)
+476 ;;=C92.61^^107^1487^9
+477 ;;^UTILITY(U,$J,358.3,37045,1,0)
+478 ;;=^358.31IA^4^2
+479 ;;^UTILITY(U,$J,358.3,37045,1,3,0)
+480 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
+481 ;;^UTILITY(U,$J,358.3,37045,1,4,0)
+482 ;;=4^C92.61
+483 ;;^UTILITY(U,$J,358.3,37045,2)
+484 ;;=^5001808
+485 ;;^UTILITY(U,$J,358.3,37046,0)
+486 ;;=C92.60^^107^1487^10
+487 ;;^UTILITY(U,$J,358.3,37046,1,0)
+488 ;;=^358.31IA^4^2
+489 ;;^UTILITY(U,$J,358.3,37046,1,3,0)
+490 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
+491 ;;^UTILITY(U,$J,358.3,37046,1,4,0)
+492 ;;=4^C92.60
+493 ;;^UTILITY(U,$J,358.3,37046,2)
+494 ;;=^5001807
+495 ;;^UTILITY(U,$J,358.3,37047,0)
+496 ;;=C92.A1^^107^1487^11
+497 ;;^UTILITY(U,$J,358.3,37047,1,0)
+498 ;;=^358.31IA^4^2
+499 ;;^UTILITY(U,$J,358.3,37047,1,3,0)
+500 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
+501 ;;^UTILITY(U,$J,358.3,37047,1,4,0)
+502 ;;=4^C92.A1
+503 ;;^UTILITY(U,$J,358.3,37047,2)
+504 ;;=^5001814
+505 ;;^UTILITY(U,$J,358.3,37048,0)
+506 ;;=C92.A0^^107^1487^12
+507 ;;^UTILITY(U,$J,358.3,37048,1,0)
+508 ;;=^358.31IA^4^2
+509 ;;^UTILITY(U,$J,358.3,37048,1,3,0)
+510 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
+511 ;;^UTILITY(U,$J,358.3,37048,1,4,0)
+512 ;;=4^C92.A0
+513 ;;^UTILITY(U,$J,358.3,37048,2)
+514 ;;=^5001813
+515 ;;^UTILITY(U,$J,358.3,37049,0)
+516 ;;=C92.51^^107^1487^13
+517 ;;^UTILITY(U,$J,358.3,37049,1,0)
+518 ;;=^358.31IA^4^2
+519 ;;^UTILITY(U,$J,358.3,37049,1,3,0)
+520 ;;=3^Acute Myelomonocytic Leukemia,In Remission
+521 ;;^UTILITY(U,$J,358.3,37049,1,4,0)
+522 ;;=4^C92.51
+523 ;;^UTILITY(U,$J,358.3,37049,2)
+524 ;;=^5001805
+525 ;;^UTILITY(U,$J,358.3,37050,0)
+526 ;;=C92.50^^107^1487^14
+527 ;;^UTILITY(U,$J,358.3,37050,1,0)
+528 ;;=^358.31IA^4^2
+529 ;;^UTILITY(U,$J,358.3,37050,1,3,0)
+530 ;;=3^Acute Myelomonocytic Leukemia,Not in Remission
+531 ;;^UTILITY(U,$J,358.3,37050,1,4,0)
+532 ;;=4^C92.50
+533 ;;^UTILITY(U,$J,358.3,37050,2)
+534 ;;=^5001804
+535 ;;^UTILITY(U,$J,358.3,37051,0)
+536 ;;=C94.40^^107^1487^17
+537 ;;^UTILITY(U,$J,358.3,37051,1,0)
+538 ;;=^358.31IA^4^2
+539 ;;^UTILITY(U,$J,358.3,37051,1,3,0)
+540 ;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
+541 ;;^UTILITY(U,$J,358.3,37051,1,4,0)
+542 ;;=4^C94.40
+543 ;;^UTILITY(U,$J,358.3,37051,2)
+544 ;;=^5001843
+545 ;;^UTILITY(U,$J,358.3,37052,0)
+546 ;;=C94.42^^107^1487^15
+547 ;;^UTILITY(U,$J,358.3,37052,1,0)
+548 ;;=^358.31IA^4^2
+549 ;;^UTILITY(U,$J,358.3,37052,1,3,0)
+550 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
+551 ;;^UTILITY(U,$J,358.3,37052,1,4,0)
+552 ;;=4^C94.42
+553 ;;^UTILITY(U,$J,358.3,37052,2)
+554 ;;=^5001845
+555 ;;^UTILITY(U,$J,358.3,37053,0)
+556 ;;=C94.41^^107^1487^16
+557 ;;^UTILITY(U,$J,358.3,37053,1,0)
+558 ;;=^358.31IA^4^2
+559 ;;^UTILITY(U,$J,358.3,37053,1,3,0)
+560 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
+561 ;;^UTILITY(U,$J,358.3,37053,1,4,0)
+562 ;;=4^C94.41
+563 ;;^UTILITY(U,$J,358.3,37053,2)
+564 ;;=^5001844
+565 ;;^UTILITY(U,$J,358.3,37054,0)
+566 ;;=D62.^^107^1487^18
+567 ;;^UTILITY(U,$J,358.3,37054,1,0)
+568 ;;=^358.31IA^4^2
+569 ;;^UTILITY(U,$J,358.3,37054,1,3,0)
+570 ;;=3^Acute Posthemorrhagic Anemia
+571 ;;^UTILITY(U,$J,358.3,37054,1,4,0)
+572 ;;=4^D62.
+573 ;;^UTILITY(U,$J,358.3,37054,2)
+574 ;;=^267986
+575 ;;^UTILITY(U,$J,358.3,37055,0)
+576 ;;=C92.41^^107^1487^19
+577 ;;^UTILITY(U,$J,358.3,37055,1,0)
+578 ;;=^358.31IA^4^2
+579 ;;^UTILITY(U,$J,358.3,37055,1,3,0)
+580 ;;=3^Acute Promyelocytic Leukemia,In Remission
+581 ;;^UTILITY(U,$J,358.3,37055,1,4,0)
+582 ;;=4^C92.41
+583 ;;^UTILITY(U,$J,358.3,37055,2)
+584 ;;=^5001802
+585 ;;^UTILITY(U,$J,358.3,37056,0)
+586 ;;=C92.40^^107^1487^20
+587 ;;^UTILITY(U,$J,358.3,37056,1,0)
+588 ;;=^358.31IA^4^2
+589 ;;^UTILITY(U,$J,358.3,37056,1,3,0)
+590 ;;=3^Acute Promyelocytic Leukemia,Not in Remission
+591 ;;^UTILITY(U,$J,358.3,37056,1,4,0)
+592 ;;=4^C92.40
+593 ;;^UTILITY(U,$J,358.3,37056,2)
+594 ;;=^5001801
+595 ;;^UTILITY(U,$J,358.3,37057,0)
+596 ;;=D56.0^^107^1487^21
+597 ;;^UTILITY(U,$J,358.3,37057,1,0)
+598 ;;=^358.31IA^4^2
+599 ;;^UTILITY(U,$J,358.3,37057,1,3,0)
+600 ;;=3^Alpha Thalassemia
+601 ;;^UTILITY(U,$J,358.3,37057,1,4,0)
+602 ;;=4^D56.0
+603 ;;^UTILITY(U,$J,358.3,37057,2)
+604 ;;=^340494
+605 ;;^UTILITY(U,$J,358.3,37058,0)
+606 ;;=D63.1^^107^1487^23
+607 ;;^UTILITY(U,$J,358.3,37058,1,0)
+608 ;;=^358.31IA^4^2
+609 ;;^UTILITY(U,$J,358.3,37058,1,3,0)
+610 ;;=3^Anemia in Chronic Kidney Disease
+611 ;;^UTILITY(U,$J,358.3,37058,1,4,0)
+612 ;;=4^D63.1
+613 ;;^UTILITY(U,$J,358.3,37058,2)
+614 ;;=^332908
+615 ;;^UTILITY(U,$J,358.3,37059,0)
+616 ;;=D63.0^^107^1487^24
+617 ;;^UTILITY(U,$J,358.3,37059,1,0)
+618 ;;=^358.31IA^4^2
+619 ;;^UTILITY(U,$J,358.3,37059,1,3,0)
+620 ;;=3^Anemia in Neoplastic Disease
+621 ;;^UTILITY(U,$J,358.3,37059,1,4,0)
+622 ;;=4^D63.0
+623 ;;^UTILITY(U,$J,358.3,37059,2)
+624 ;;=^321978
+625 ;;^UTILITY(U,$J,358.3,37060,0)
+626 ;;=D63.8^^107^1487^22
+627 ;;^UTILITY(U,$J,358.3,37060,1,0)
+628 ;;=^358.31IA^4^2
+629 ;;^UTILITY(U,$J,358.3,37060,1,3,0)
+630 ;;=3^Anemia in Chronic Diseases Classified Elsewhere
+631 ;;^UTILITY(U,$J,358.3,37060,1,4,0)
+632 ;;=4^D63.8
+633 ;;^UTILITY(U,$J,358.3,37060,2)
+634 ;;=^5002343
+635 ;;^UTILITY(U,$J,358.3,37061,0)
+636 ;;=C22.3^^107^1487^27
+637 ;;^UTILITY(U,$J,358.3,37061,1,0)
+638 ;;=^358.31IA^4^2
+639 ;;^UTILITY(U,$J,358.3,37061,1,3,0)
+640 ;;=3^Angiosarcoma of Liver
+641 ;;^UTILITY(U,$J,358.3,37061,1,4,0)
+642 ;;=4^C22.3
+643 ;;^UTILITY(U,$J,358.3,37061,2)
+644 ;;=^5000936
+645 ;;^UTILITY(U,$J,358.3,37062,0)
+646 ;;=D61.9^^107^1487^28
+647 ;;^UTILITY(U,$J,358.3,37062,1,0)
+648 ;;=^358.31IA^4^2
+649 ;;^UTILITY(U,$J,358.3,37062,1,3,0)
+650 ;;=3^Aplastic Anemia,Unspec
+651 ;;^UTILITY(U,$J,358.3,37062,1,4,0)
+652 ;;=4^D61.9
+653 ;;^UTILITY(U,$J,358.3,37062,2)
+654 ;;=^5002342
+655 ;;^UTILITY(U,$J,358.3,37063,0)
+656 ;;=D56.1^^107^1487^34
+657 ;;^UTILITY(U,$J,358.3,37063,1,0)
+658 ;;=^358.31IA^4^2
+659 ;;^UTILITY(U,$J,358.3,37063,1,3,0)
+660 ;;=3^Beta Thalassemia
+661 ;;^UTILITY(U,$J,358.3,37063,1,4,0)
+662 ;;=4^D56.1
+663 ;;^UTILITY(U,$J,358.3,37063,2)
+664 ;;=^340495
+665 ;;^UTILITY(U,$J,358.3,37064,0)
+666 ;;=C83.79^^107^1487^36
+667 ;;^UTILITY(U,$J,358.3,37064,1,0)
+668 ;;=^358.31IA^4^2
+669 ;;^UTILITY(U,$J,358.3,37064,1,3,0)
+670 ;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
+671 ;;^UTILITY(U,$J,358.3,37064,1,4,0)
+672 ;;=4^C83.79
+673 ;;^UTILITY(U,$J,358.3,37064,2)
+674 ;;=^5001600
+675 ;;^UTILITY(U,$J,358.3,37065,0)
+676 ;;=C83.70^^107^1487^37
